ALK-Abello A/S - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for ALK-Abello A/S. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

ALK-Abello A/S. The principal activity of the Group is developing products for diagnosis, prevention and treatment of allergies. The Group operates through one business area namely: Allergy sector. The Allergy sector operates within allergy vaccination - injection-based and drop-based vaccines, the only treatment able to cure allergy rather than just alleviate symptoms. In addition to the existing business, the Group has developed a pipeline of projects which have the potential to bring crucial, innovative change to the treatment and cure of allergy. The Group operates subsidiaries in France, Netherlands, Italy, Sweden, Germany, UK and USA, and has sales offices in China, Finland, Norway and Denmark. In 2008 the Group acquired Western Allergy Services Ltd. and allergy vacinationation activities of its former distributior in cannada.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report